Balsalazide Disodium is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Avkare, Inc.. The primary component is Balsalazide Disodium.
| Product ID | 42291-157_62d7e2d4-a1ac-5faf-e053-2a91aa0a8e58 |
| NDC | 42291-157 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Balsalazide Disodium |
| Generic Name | Balsalazide Disodium |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-06-29 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077883 |
| Labeler Name | AvKARE, Inc. |
| Substance Name | BALSALAZIDE DISODIUM |
| Active Ingredient Strength | 750 mg/1 |
| Pharm Classes | Aminosalicylate [EPC],Aminosalicylic Acids [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2016-06-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077883 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-06-29 |
| Ingredient | Strength |
|---|---|
| BALSALAZIDE DISODIUM | 750 mg/1 |
| SPL SET ID: | 9db29007-40aa-e3f4-22e4-f8749756a11e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0079 | Balsalazide Disodium | Balsalazide Disodium |
| 42291-157 | Balsalazide Disodium | Balsalazide Disodium |
| 50268-102 | Balsalazide Disodium | Balsalazide Disodium |
| 60429-952 | Balsalazide Disodium | Balsalazide Disodium |
| 60505-2575 | Balsalazide Disodium | Balsalazide Disodium |
| 63629-8301 | Balsalazide Disodium | Balsalazide Disodium |
| 68682-750 | balsalazide disodium | balsalazide disodium |
| 72789-149 | Balsalazide Disodium | Balsalazide Disodium |
| 65649-101 | Colazal | balsalazide disodium |
| 65649-102 | GIAZO | balsalazide disodium |